Securities code: Pharmaron Beijing Co.Ltd(300759) securities abbreviation: Pharmaron Beijing Co.Ltd(300759) Announcement No.: 2022020 Pharmaron Beijing Co.Ltd(300759) (Beijing) new drug Technology Co., Ltd
Announcement on holding 2021 online performance briefing
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Pharmaron Beijing Co.Ltd(300759) (Beijing) new drug Technology Co., Ltd. (hereinafter referred to as “the company”) is scheduled to hold the 2021 annual performance presentation on panorama.com from 15:00 to 17:00 on Friday, April 8, 2022. This annual performance presentation will be held remotely. Investors can log in to the “investor relations interactive platform” of panorama.com（ http://ir.p5w.net. ）Participate in this annual performance briefing.
Present at this briefing are: Mr. Boliang Lou, chairman and general manager of the company, Mr. Li Chengzong, financial director and Secretary of the board of directors, Mr. Yu Jian, independent non-executive director and Mr. Zheng Rui, sponsor representative of Orient Securities Company Limited(600958) underwriting sponsor Co., Ltd.
In order to fully respect investors and improve the pertinence of exchanges, we are now soliciting questions from investors in advance for the company’s 2021 annual performance description, and widely listen to the opinions and suggestions of investors. Investors can visit before 15:00 on Thursday, April 7, 2022 http://ir.p5w.net./zj/ , or scan the QR code below to enter the question collection topic page. Investors are kindly requested to submit your concerns through the panorama system, so that the company can answer the questions generally concerned by investors at the performance briefing and improve the pertinence of the performance briefing. During the exchange of this activity, investors can still log in to the activity interface for interactive questions.
Investors are welcome to actively participate in this online briefing.
(QR code of question collection special page)
It is hereby announced.
Pharmaron Beijing Co.Ltd(300759) (Beijing) new drug Technology Co., Ltd. board of directors March 28, 2022
